CClinicalTrials.gg
Active, not recruitingNCT06552780Updated Aug 19, 2024

High Intensity Laser Versus Ischemic Compression on Myofascial Trigger Points in the Upper Trapezius

An interventional study of TENs , ultrasound therapy in Neck Pain, sponsored by Cairo University. Active, not recruiting at 1 site in Egypt. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2024-08-19.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 9 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
63
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

TO Investigate the effect of high intensity laser versus ischemic compression on myofascial trigger points on neck pain, cervical range of motion,pressure pain thershold and cervical disability and to show that the more effectivness therapy will provide significant clinical value

Read the detailed description

Randomized controlled Trial , participants will be assigned into three groups (study group A ,study group B and study group c ) Subject selection will be 63 subjects , 21 subjects in each group with trigger points in the upper trapezius.

Groups

02

Conditions studied

  • Neck Pain

Browse trials for

Keywords

  • "myofascial pain syndrome" "trigger points" "high intensity laser " "ischemic compression"
03

In context

Neck Pain

1,232 studies on the registry are indexed under Neck Pain; 255 are open to participants now.

This study's planned enrollment of 63 is above the median of 52 across 1,004 interventional studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • The age of patients range from 20 to 50 years .
  • patient Body mass index starting from 19 to 25 kg\m.
  • presence of myofascial trigger points in the shortened upper trapezius muscle evaluated .

Exclusion criteria

Exclusion Criteria:

  • patients with fibromyalgia syndrome.
  • cancer or tumor or any type diagnosed .
  • patients with disc herniation or spinal canal stenosis.
  • pregnancy -
  • patients diagnosed with epilepsy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
63 participants (estimated)

Study arms

  • Experimental
    high intensity laser , TENs and ultrasound and isometric exercise

    Group A ( study group )will receive high intensity laser ,TENs , ultrasound therapy , and isometric exercise.

    Device: TENs , ultrasound therapy

  • Experimental
    ischemic compression ,TENs , ultrasound and isometric exercise

    Group B ( study group) will receive ischemic compression ,TENs and ultrasound therapy and isometric exercise.

    Device: TENs , ultrasound therapy

  • Experimental
    TENs , ultrasound and isometric exercise

    Group C (control group ) will receive TENs and ultrasound therapy and isometric exercise only.

    Device: TENs , ultrasound therapy

Interventions

  • DeviceTENs , ultrasound therapy

    effect of high intensity laser versus ischemic compression on myofascial trigger points in the upper trapezius

    Also known as: high intensity (power) laser, ischemic compression, TENs , ultrasound therapy , isometric exercise and stretching exercise.

06

What researchers measure

Primary outcomes

  1. cervical range of motion (CROM)

    All the cervical active movements will be measured by cervical range of motion device (CROM) especially in cervical flexion ,extension and medial and lateral rotation.one tester will document the results. cervical range of motion (cROM) will be measured by using Electronic CROM Goniometer in all ranges.

    Time frame: 30 seconds

Secondary outcomes

  1. cervical pain

    Cervical pain will be measured by Cervical range of motion device (CROM) .The patient will actively perform cervical movements in flexion ,extension and medial and lateral rotation then one tester will document the results as VAS will be used to measure pain levels .The VAS is a 10_cm line divided into 10 equal sections , with 10 expressing "unbearable pain " and 0 indicating no pain .each patient will be asked to point on this line to their level of neck pain .as pain level decreases ,the patient state improves. Pain will be assessed before and after treatment.

    Time frame: one minute

Other outcomes

  1. pressure pain threshold (PPT)

    Pressure pain threshold (PPT) ,measured by Algometer is defined as the point at which painless stimulation such as pressure turns into a painful sensation,so that we will measure PPT for each patient before and after treatment by one tester as pressure Algometry is a method that objectively describes PPT

    Time frame: 10 seconds

07

Study locations

1 site
  • Faculty of physical therapy
    Giza, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06552780
Lead sponsor
Cairo University
Responsible party
Alaa mohamed abdelfatah elrefaey (Demonstrator, Cairo University) — Principal investigator
First posted
Aug 14, 2024
Start date
May 19, 2024
Primary completion
Jan 1, 2025 (estimated)
Completion
Feb 1, 2025 (estimated)
Last update
Aug 19, 2024

Study contacts

RAGIAA KAMEL, PROFFESOR DR
principal investigator · RAGIAA M KAMEL , PROF DR

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion